Compare Cadila Healthcare with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs STERLING BIOTECH - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE STERLING BIOTECH CADILA HEALTHCARE/
STERLING BIOTECH
 
P/E (TTM) x 28.2 -0.4 - View Chart
P/BV x 4.5 0.0 31,873.4% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 CADILA HEALTHCARE   STERLING BIOTECH
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-20
STERLING BIOTECH
Dec-13
CADILA HEALTHCARE/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs35211 3,355.2%   
Low Rs2073 6,073.5%   
Sales per share (Unadj.) Rs139.226.8 519.4%  
Earnings per share (Unadj.) Rs11.8-15.0 -78.7%  
Cash flow per share (Unadj.) Rs18.6-5.5 -339.9%  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs101.454.9 184.7%  
Shares outstanding (eoy) m1,023.74267.87 382.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.00.3 774.0%   
Avg P/E ratio x23.7-0.5 -5,110.9%  
P/CF ratio (eoy) x15.0-1.3 -1,182.7%  
Price / Book Value ratio x2.80.1 2,176.9%  
Dividend payout %29.80-   
Avg Mkt Cap Rs m286,0331,862 15,364.1%   
No. of employees `00013.41.4 990.0%   
Total wages/salary Rs m24,145547 4,415.7%   
Avg. sales/employee Rs Th10,632.75,303.3 200.5%   
Avg. wages/employee Rs Th1,801.2403.8 446.0%   
Avg. net profit/employee Rs Th898.5-2,959.0 -30.4%   
INCOME DATA
Net Sales Rs m142,5317,181 1,984.9%  
Other income Rs m1,13943 2,673.7%   
Total revenues Rs m143,6707,223 1,989.0%   
Gross profit Rs m24,198947 2,555.5%  
Depreciation Rs m6,9652,543 273.9%   
Interest Rs m3,4184,377 78.1%   
Profit before tax Rs m14,954-5,931 -252.1%   
Minority Interest Rs m2880-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,198-1,924 -166.2%   
Profit after tax Rs m12,044-4,007 -300.6%  
Gross profit margin %17.013.2 128.7%  
Effective tax rate %21.432.4 65.9%   
Net profit margin %8.5-55.8 -15.1%  
BALANCE SHEET DATA
Current assets Rs m87,15414,335 608.0%   
Current liabilities Rs m82,69449,809 166.0%   
Net working cap to sales %3.1-494.0 -0.6%  
Current ratio x1.10.3 366.2%  
Inventory Days Days71403 17.7%  
Debtors Days Days94171 55.0%  
Net fixed assets Rs m133,23655,432 240.4%   
Share capital Rs m1,024268 382.2%   
"Free" reserves Rs m102,73313,935 737.2%   
Net worth Rs m103,75714,701 705.8%   
Long term debt Rs m32,1469,478 339.2%   
Total assets Rs m236,86673,988 320.1%  
Interest coverage x5.4-0.4 -1,514.3%   
Debt to equity ratio x0.30.6 48.1%  
Sales to assets ratio x0.60.1 620.0%   
Return on assets %6.50.5 1,303.2%  
Return on equity %11.6-27.3 -42.6%  
Return on capital %13.7-6.4 -213.7%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m52,7521,860 2,836.4%   
Fx outflow Rs m14,50425 58,272.4%   
Net fx Rs m38,2481,835 2,084.5%   
CASH FLOW
From Operations Rs m25,0541,719 1,457.7%  
From Investments Rs m-10,123-3,148 321.5%  
From Financial Activity Rs m-10,9421,426 -767.3%  
Net Cashflow Rs m3,989-3 -117,323.5%  

Share Holding

Indian Promoters % 74.8 33.9 220.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 0.0 -  
FIIs % 5.9 9.9 59.6%  
ADR/GDR % 0.0 16.9 -  
Free float % 11.0 39.3 28.0%  
Shareholders   44,069 21,482 205.1%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   PIRAMAL ENTERPRISES  NOVARTIS  DR. DATSONS LABS  PROCTER & GAMBLE HEALTH  GSK PHARMA  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Crucial Week Ahead for the Indian Stock Market(Momentum Moves)

The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.

Related Views on News

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jan 22, 2021 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - TORRENT PHARMA COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS